- ASSISTANT PROFESSOR Medicine, Cardiology
American Board of Internal Medicine
MD, Albert Einstein College of Medicine
Residency, Internal Medicine
New York Presbyterian Hosp-Cornell
Montefiore Medical Center
- Dr. Gitig has experience treating patients with a broad range of cardiac problems, including coronary artery disease, heart valve disorders, hypertrophic cardiomyopathy, congestive heart failure, and atrial fibrillation. He has a strong background in noninvasive imaging tools, such as echocardiography and nuclear stress testing. Dr Gitig’s interest is in using noninvasive tests to define patients’ risk for cardiac illness, in order to develop targeted, aggressive primary and secondary prevention regimens.
Dr. Gitig treats members of the Westchester community from a wide array of backgrounds. He has developed an interest in working with the growing elderly population of Yonkers. It is an exciting era in cardiology, with less invasive techniques being developed to treat mitral and aortic valve disease, relieve coronary artery obstructions, and help prevent strokes from atrial fibrillation. By judiciously directing appropriate patients towards novel technologies and medications, Dr. Gitig has been able to help many of his older patients regain an improved quality of life, and remain active, thriving members of their communities.
Dr. Gitig maintains a close working relationship with many of his colleagues on the full-time faculty of Mount Sinai’s Division of Cardiology, allowing him to keep abreast of exciting advances in the field. He takes pride in being able to serve as a bridge for his Westchester patients, facilitating their access to cutting-edge treatments, including clinical trials of technologies and devices which they might otherwise not have at their disposal.
Phi Beta Kappa Honor Society
University of Pennsylvania
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Gitig did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.